 | Up a level |
Moreno, Lucas; Weston, Rebekah; Owens, Cormac; Valteau-Couanet, Dominique; Gambart, Marion; Castel, Victoria; Zwaan, C Michel; Nysom, Karsten; Gerber, Nicolas; Castellano, Aurora; Laureys, Genevieve; Ladenstein, Ruth; Rössler, Jochen; Makin, Guy; Murphy, Dermot; Morland, Bruce; Vaidya, Sucheta; Thebaud, Estelle; van Eijkelenburg, Natasha; Tweddle, Deborah A; ... (2024). Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 42(10), pp. 1135-1145. American Society of Clinical Oncology 10.1200/JCO.23.00458
Morland, Bruce; Kepak, Tomas; Dallorso, Sandro; Sevilla, Julian; Murphy, Dermot; Luksch, Roberto; Yaniv, Isaac; Bader, Peter; Rössler, Jochen; Bisogno, Gianni; Maecker-Kolhoff, Britta; Lang, Peter; Zwaan, C Michel; Sumerauer, David; Kriván, Gergely; Bernard, John; Liu, Qianying; Doyle, Eileen; Locatelli, Franco (2020). Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC). Bone marrow transplantation, 55(9), pp. 1744-1753. Springer Nature 10.1038/s41409-020-0836-2
